These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 1883526)

  • 1. Hypercalcemia of malignancy: pathophysiology, diagnosis and treatment.
    Mosekilde L; Eriksen EF; Charles P
    Crit Rev Oncol Hematol; 1991; 11(1):1-27. PubMed ID: 1883526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms and treatment of hypercalcemia of malignancy.
    Clines GA
    Curr Opin Endocrinol Diabetes Obes; 2011 Dec; 18(6):339-46. PubMed ID: 21897221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenesis of humoral hypercalcaemia of malignancy.
    Ralston SH
    Lancet; 1987 Dec; 2(8573):1443-6. PubMed ID: 2892002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Humoral hypercalcemia of malignancy. The role of parathyroid hormone-related protein.
    Insogna KL
    Endocrinol Metab Clin North Am; 1989 Sep; 18(3):779-94. PubMed ID: 2673773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid hormone-related protein and hypercalcemia.
    Rankin W; Grill V; Martin TJ
    Cancer; 1997 Oct; 80(8 Suppl):1564-71. PubMed ID: 9362423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathophysiology and management of severe hypercalcemia.
    Nussbaum SR
    Endocrinol Metab Clin North Am; 1993 Jun; 22(2):343-62. PubMed ID: 8325291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of hypercalcemia of malignancy.
    Solimando DA
    Am J Health Syst Pharm; 2001 Nov; 58 Suppl 3():S4-7. PubMed ID: 11757205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone resorption and humoral hypercalcemia of malignancy: stimulation of bone resorption in vitro by tumor extracts is inhibited by prostaglandin synthesis inhibitors.
    Minkin C; Fredericks RS; Pokress S; Rude RK; Sharp CF; Tong M; Singer FR
    J Clin Endocrinol Metab; 1981 Nov; 53(5):941-7. PubMed ID: 6793615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein.
    Wysolmerski JJ; Broadus AE
    Annu Rev Med; 1994; 45():189-200. PubMed ID: 8198376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of plasma PTH-rp in patients with hypercalcemia of malignancy treated with bisphosphonate.
    Wimalawansa SJ
    Cancer; 1994 Apr; 73(8):2223-30. PubMed ID: 8156530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignancy-associated hypercalcemia].
    Yamaguchi K
    Gan To Kagaku Ryoho; 1991 Mar; 18(3):343-9. PubMed ID: 2003737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Onco-nephrology: the pathophysiology and treatment of malignancy-associated hypercalcemia.
    Rosner MH; Dalkin AC
    Clin J Am Soc Nephrol; 2012 Oct; 7(10):1722-9. PubMed ID: 22879438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypercalcemia of malignancy in the palliative care patient: a treatment strategy.
    Kovacs CS; MacDonald SM; Chik CL; Bruera E
    J Pain Symptom Manage; 1995 Apr; 10(3):224-32. PubMed ID: 7543127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of malignancy associated hypercalcemia].
    Tai N; Inoue D
    Clin Calcium; 2014 Aug; 24(8):1223-8. PubMed ID: 25065875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperparathyroidism, humoral hypercalcemia of malignancy, and the anabolic actions of parathyroid hormone and parathyroid hormone-related protein on the skeleton.
    Stewart AF
    J Bone Miner Res; 2002 May; 17(5):758-62. PubMed ID: 12009005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy.
    Syed MA; Horwitz MJ; Tedesco MB; Garcia-Ocaña A; Wisniewski SR; Stewart AF
    J Clin Endocrinol Metab; 2001 Apr; 86(4):1525-31. PubMed ID: 11297578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypercalcemia of malignancy: a review of advances in pathophysiology.
    Kaplan M
    Oncol Nurs Forum; 1994 Jul; 21(6):1039-46; quiz 1047-8. PubMed ID: 7971410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tumor-secreted protein associated with human hypercalcemia of malignancy. Biology and molecular biology.
    Rosenblatt M; Caulfield MP; Fisher JE; Horiuchi N; Mckee RL; Rodan SB; Thiede MA; Thompson DD; Seedor JG; Nutt RE
    Ann N Y Acad Sci; 1988; 548():137-45. PubMed ID: 2854715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Malignant humoral hypercalcemia and the parathyroid hormone related protein].
    Jemtland R; Rian E; Gautvik KM
    Tidsskr Nor Laegeforen; 1991 May; 111(14):1738-42. PubMed ID: 2063384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercalcemia in malignancy.
    Strewler GJ; Nissenson RA
    West J Med; 1990 Dec; 153(6):635-40. PubMed ID: 2293469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.